Gabapentin, sold under the brand name Neurontin among others, is an anticonvulsant medication primarily used to treat partial seizures and neuropathic...

gabapentin. It was designed for increased oral bioavailability over gabapentin, and human trials showed it to produce extended release of gabapentin with...

United States in 2004. It was developed as a successor to the related gabapentin. It is available as a generic medication. In 2021, it was the 73rd most...

the gabapentin receptor (α2δ subunit), as it is the target of the drugs gabapentin and pregabalin. Clinically used gabapentinoids include gabapentin, pregabalin...

seizures and severe agitation. Approved: Gabapentin (Neurontin) Gabapentin enacarbil (Horizant, Regnite) Gabapentin Extended-Release (Gralise) Pregabalin...

used transdermally (applied topically to the skin) in combination with gabapentin and clonidine prepared at a compounding pharmacy. Common side effects...

inhibitor and GABA reuptake inhibitor Gabapentin – anticonvulsant; inhibitor of α2δ subunit-containing VGCCs Gabapentin enacarbil – used for the treatment...

Phenibut also binds to and blocks α2δ subunit-containing VDCCs, similarly to gabapentin and pregabalin, and hence is a gabapentinoid. Both (R)-phenibut and (S)-phenibut...

most widely attempted medication is gabapentin, with one case series finding that seven of eight patients on gabapentin showed improvement in attack frequency...

Pregabalin (2004) Mirogabalin (2019) (Japan only) Gabapentin (1993) Gabapentin enacarbil (Horizant) (2011) Gabapentin extended release (Gralise) (1996) Gabapentinoids...